Bank of New York Mellon
BNGO icon

Bank of New York Mellon’s Bionano Genomics BNGO Stock Holding History

Bank of New York Mellon’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-212
Closed -$24.1K – 4177
2023
Q4 		$24.1K Hold
212
– – ﹤0.01% 4223
2023
Q3 		$38.6K Sell
212
-302
-59% -$79.1K ﹤0.01% 4187
2023
Q2 		$188K Sell
514
-1,688
-77% -$762K ﹤0.01% 3994
2023
Q1 		$1.47M Sell
2,202
-16
-0.7% -$14.2K ﹤0.01% 2964
2022
Q4 		$1.94M Buy
2,218
+12
+0.5% +$15.1K ﹤0.01% 2866
2022
Q3 		$2.42M Buy
2,206
+158
+8% +$209K ﹤0.01% 2726
2022
Q2 		$1.7M Buy
2,048
+384
+23% +$395K ﹤0.01% 2928
2022
Q1 		$2.58M Sell
1,664
-76
-4% -$103K ﹤0.01% 2799
2021
Q4 		$3.12M Buy
1,740
+38
+2% +$102K ﹤0.01% 2730
2021
Q3 		$5.62M Buy
1,702
+175
+11% +$612K ﹤0.01% 2428
2021
Q2 		$6.72M Buy
1,527
+1,296
+561% +$5.12M ﹤0.01% 2351
2021
Q1 		$1.12M Buy
231
+153
+196% +$863K ﹤0.01% 3261
2020
Q4 		$144K Hold
78
– – ﹤0.01% 4032
2020
Q3 		$30K Hold
78
– – ﹤0.01% 4070
2020
Q2 		$24K Hold
78
– – ﹤0.01% 4045
2020
Q1 		$21K Buy
+78
New +$44K ﹤0.01% 4052

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon's BNGO Position: Q1 2024 in Review

Bank of New York Mellon sold out of Bionano Genomics (BNGO) in Q1 2024, closing a stake of 212 shares — an estimated $24.1K sold.

Bank of New York Mellon first reported a position in BNGO in Q1 2020 and held it in 16 quarters. The position peaked at $6.72M in Q2 2021. 55 funds tracked by Wall St. Rank hold BNGO as of Q1 2024.

  • Bank of New York Mellon reported no remaining Bionano Genomics position as of Q1 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 212 Bionano Genomics shares in Q1 2024, an estimated $24.1K.
  • Bank of New York Mellon first reported a position in Bionano Genomics in Q1 2020 and held it in 16 quarters.
  • Bank of New York Mellon's Bionano Genomics position peaked at $6.72M in Q2 2021.
  • 55 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2024.

Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.